Incidence of endometrial spotting or bleeding during continuous-combined estrogen-progestin therapy in postmenopausal women with and without hypertension
© 2015 by The North American Menopause Society. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. Objective: Endometrial spotting or bleeding is a common adverse effect among women taking continuouscombined estrogen-progestin therapy. The renin- angiotensin-aldosterone system plays a...
محفوظ في:
المؤلفون الرئيسيون: | Intira Sriprasert, Hind Beydoun, Vanessa Barnabei, Rami Nassir, Andrea Z. LaCroix, David F. Archer |
---|---|
التنسيق: | دورية |
منشور في: |
2018
|
الموضوعات: | |
الوصول للمادة أونلاين: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84942509445&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/44870 |
الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
المؤسسة: | Chiang Mai University |
مواد مشابهة
-
Incidence of endometrial spotting or bleeding during continuous-combined estrogen-progestin therapy in postmenopausal women with and without hypertension
بواسطة: Intira Sriprasert, وآخرون
منشور في: (2018) -
A review of the endometrial histologic effects of progestins and progesterone receptor modulators in reproductive age women
بواسطة: Dinh A., وآخرون
منشور في: (2015) -
Etiologies for postmenopausal bleeding and diagnostic values of endometrial biopsy
بواسطة: Orawin Vallibhakara, وآخرون
منشور في: (2019) -
Use of vaginosonographic measurements of endometrial thickness in the identification of abnormal endometrium in peri- and postmenopausal bleeding
بواسطة: Tongsong T., وآخرون
منشور في: (2014) -
Clinical and pathological responses of progestin therapy for non-atypical endometrial hyperplasia: A prospective study
بواسطة: Manee Rattanachaiyanont, وآخرون
منشور في: (2018)